Solicitation of Nominations for Appointment to CDC's Advisory Committee to the Director (ACD) Laboratory Workgroup (LW); Amended Notice
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Centers for Disease Control and Prevention (CDC) gives notice of a change in the solicitation of CDC's Advisory Committee to the Director (ACD) Laboratory Workgroup (LW), in the original FRN published on May 4, 2022. The request for nominations is being amended to update the language in the supplementary information section of the notice, restated below.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 92 (Thursday, May 12, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 92 (Thursday, May 12, 2022)]
[Notices]
[Pages 29160-29161]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-10142]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to CDC's Advisory
Committee to the Director (ACD) Laboratory Workgroup (LW); Amended
Notice
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Amended notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) gives
notice of a change in the solicitation of CDC's Advisory Committee to
the Director (ACD) Laboratory Workgroup (LW), in the original FRN
published on May 4, 2022. The request for nominations is being amended
to update the language in the supplementary information section of the
notice, restated below.
DATES: Nominations for membership on the LW workgroup must be received
no later than May 16, 2022. Late nominations will not be considered for
membership.
ADDRESSES: All nominations (cover letters and curriculum vitae) should
be emailed to <a href="/cdn-cgi/l/email-protection#1e52495f5d5a5e7d7a7d30797168"><span class="__cf_email__" data-cfemail="38746f797b7c785b5c5b165f574e">[email protected]</span></a> with the subject line: ``Nomination for CDC
ACD LW Workgroup.''
FOR FURTHER INFORMATION CONTACT: Lauren Hoffmann, MA, Office of the
Chief of Staff, Centers for Disease Control and Prevention, 1600
Clifton Road NE, Mailstop H21-10, Atlanta, Georgia 30329-4027;
Telephone: (404) 639-7000; Email: <a href="/cdn-cgi/l/email-protection#a7ebf0e6e4e3e7c4c3c489c0c8d1"><span class="__cf_email__" data-cfemail="1f53485e5c5b5f7c7b7c31787069">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Background: The purpose of the ACD, CDC is to advise the Secretary,
HHS, and the Director, CDC, on policy and broad strategies that will
enable CDC to fulfill its mission of protecting health through health
promotion, prevention, and preparedness. The ACD, CDC consists of up to
15 non-federal members, including the Chair, knowledgeable in areas
pertinent to the CDC mission, such as health policy, public health,
global health, preparedness, preventive medicine, the faith-based and
community-based sector, and allied fields. The request for nominations
in the original published FRN was published in the Federal Register on
May 4, 2022, Volume 87, Number 86, page 26358.
Purpose: The establishment and formation of the LW is to provide
input to the ACD, CDC on agency-wide activities related to laboratory
quality management, continuous laboratory quality improvement, and
laboratory diagnostic testing to support public health programs and
investigations. The LW membership will consist of up to 15 members. It
will be co-chaired by two current ACD, CDC Special Government
Employees. The LW co-chairs will present their findings, observations,
and work products at one or more ACD, CDC meetings for discussion,
deliberation, and decisions (final recommendations to CDC).
Nomination Criteria: LW members will serve terms ranging from six
months to one year and be required to attend LW meetings approximately
1-2 times per month (virtually or in person), and contribute time
between meetings for research, consultation, discussion, and writing
assignments.
Nominations are being sought for individuals who have the expertise
and qualifications necessary to contribute to the accomplishments of
the committee's/workgroup's objectives. Nominees will be selected based
on expertise in the fields of public health laboratory science and
practice, laboratory quality management, diagnostic regulations, and
clinical laboratory testing and research. To ensure a diverse workgroup
composition, nominees with front line and field experience at the
local, state, tribal, and territorial levels are encouraged to apply.
Federal employees will not be considered for membership. Selection of
members is based on candidates' qualifications to contribute to the
accomplishment of the LW's objectives.
HHS policy stipulates that membership be balanced in terms of
points of view represented and the workgroup's function. Appointments
shall be made without discrimination based on age, race, ethnicity,
gender, sexual orientation, gender identity, HIV status, disability,
and cultural, religious, or socioeconomic status. Nominees cannot be
full-time employees of the U.S. Government. Current participation on
federal workgroups or prior experience serving on a federal advisory
committee does not disqualify a candidate; however, HHS policy is to
avoid excessive individual service on advisory committees and multiple
committee memberships. Interested candidates should submit the
following items:
[ssquf] A one-half to one-page cover letter that includes your
understanding of, and commitment to, the time and work necessary; one
to two sentences on your background and experience; and one to two
sentences on the skills/perspective you would bring to the LW.
[ssquf] Current curriculum vitae which highlights the experience
and work history being sought relevant to the criteria set forth above,
including complete contact information (telephone numbers, mailing
address, email address).
Nominations may be submitted by the candidate him or herself, or by
the person/organization recommending the candidate no later than May
16, 2022. All nominations (cover letters and curriculum vitae) should
be emailed to <a href="/cdn-cgi/l/email-protection#c9859e888a8d89aaadaae7aea6bf"><span class="__cf_email__" data-cfemail="68243f292b2c280b0c0b460f071e">[email protected]</span></a> with the subject line: ``Nomination for CDC
ACD LW Workgroup.''
[[Page 29161]]
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-10142 Filed 5-11-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.